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Abstract
The recommended antibiotic regimen against Coxiella burnetii, the etiological agent of Q fever, is based on a semi-synthetic,
second-generation tetracycline, doxycycline. Here, we report on the comparison of the proteomes of a C. burnetii reference
strain either cultured under control conditions or under tetracycline stress conditions. Using the MS-driven combined
fractional diagonal chromatography proteomics technique, out of the 531 proteins identified, 5 and 19 proteins were found
significantly up- and down-regulated respectively, under tetracycline stress. Although the predicted cellular functions of
these regulated proteins did not point to known tetracycline resistance mechanisms, our data clearly reveal the plasticity of
the proteome of C. burnetii to battle tetracycline stress. Finally, we raise several plausible hypotheses that could further lead
to more focused experiments on studying tetracycline resistance in C. burnetii and thus reduced treatment failures of Q
fever.
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Introduction
Coxiella burnetii, until recently considered to be an obligatory
intracellular bacterium [1,2], is the causative agent of Q fever.
Since its first documentation in abattoir workers in Queensland
(Australia), where the need for diagnosis based on vague febrile
symptoms led to an illness named Query (Q) fever [3], the clinical
manifestations observed are numerous. In fact, the main
characteristic of Q fever is its clinical polymorphism. Although
C. burnetii infection can result in outcomes ranging from
asymptomatic seroconversion to death, the most typical clinical
manifestations of acute Q fever are fever (91%), severe headaches
(51%), myalgias (37%), arthralgias (27%) and cough (34%) [4].
Chronic Q fever can develop many months or years after
infection, manifesting itself in the majority of cases as endocarditis
[5] and more rarely as osteomyelitis, osteoarthritis, hepatitis, and
other manifestations [6].
Treatment of both acute as well as chronic Q fever is based on
doxycycline, a semi-synthetic and second-generation tetracycline
invented and clinically developed in the early 1960s [7] [8]. The
recommended regimen for treating acute Q fever is doxycycline
for two weeks, with fluoroquinolones suggested as reliable
alternatives, in particular for patients with Q fever meningoen-
cephalitis, due to their efficient penetration into the cerebrospinal
fluid [8]. Further, cotrimoxazole and rifampin can be used in cases
of tetracycline contraindication [4].
Doxycycline in combination with hydroxychloroquine is the main
therapy for treating patients with chronic Q fever. However, the
optimal duration of therapy for chronic Q fever is unknown and
ranges from 18 months to life-long antibiotic administration [9]. Of
interest is that C. burnetii strains resistant to doxycycline (MIC of
8 mg/mL) have been isolated from patients with Q fever endocarditis
[10]. Furthermore, C. burnetii was recovered from cardiac valve tissue
removed from a patient with Q fever endocarditis despite 4 years of
antibiotic therapy with tetracycline [11].
Tetracyclines are broad-spectrum agents and exhibit antibiotic
activity against a wide range of microorganisms. Their favorable
antimicrobial properties and the absence of major, adverse side-
effects have led to their extensive use in treating infected humans
and animals. Tetracyclines inhibit bacterial protein synthesis by
preventing the association of aminoacyl-tRNA with the bacterial
ribosome [12]. Indeed, binding of tetracyclines sterically blocks
aminoacyl-tRNA binding and, as a result, inhibits protein
synthesis [13]. Tetracyclines binding to ribosomes is reversible,
hence explaining their bacteriostatic, rather than bactericidal
effects [12].
Resistance to tetracyclines mainly occurs through five mecha-
nisms: production of ribosomal protection proteins (RPPs), active
efflux of tetracycline from the cell, decreased drug permeability,
mutation of the antibiotic target and their enzymatic degradation.
Of note is that the first two mechanisms currently predominate in
clinical settings [14].
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burnetii (CbuG_Q212) either propagated in the presence of
doxycycline or propagated without any antibiotic present. The
CbuG_Q212 strain was particularly chosen since it is considered
as a prototype C. burnetii chronic disease isolate [15]. Chances are
that a chronic disease isolate may remain under tetracycline stress
for prolonged periods of time compared to an acute disease
reference strain such as Nine Mile in in vivo conditions and might
have increased possibilities to develop drug resistance. The
COFRADIC proteomics technology (COmbined FRActional
DIagonal Chromatography) was used here, which is a so-called
gel-free proteomics technology based on the principle of diagonal
chromatography [16]. Since COFRADIC depends on mass
spectrometry (MS) for protein identification and quantification,
typically a more comprehensive proteome coverage is achieved as
compared to gel-based proteomics methods [16]. The major aim
of the current study was to provide further insights into possible
adaptations of the bacterial proteome under antibiotic stress
conditions. The ultimate goal we envision is to identify the
molecular mechanisms Coxiella burnetii can implement to resist
protein synthesis inhibition by tetracyclines..
Results
Protein identification
The COFRADIC technology used here enriches for methio-
nine-containing peptides out of protease-digested proteomes with
the aim to reduce the sample complexity before the actual LC-
MS/MS analysis, and thereby, attempts to increase the overall
proteome coverage [16]. In total, 13,271 MS/MS spectra were
identified, 8,208 (62%) of which were linked to peptides containing
methionine. These spectra identified 1,998 unique peptides in 800
proteins (Table 1). In order to reduce the number of possible false
positive identification, stringent filtering criteria were used on all
peptide-to-spectrum matches (Table 2). These filtering criteria
reduced the number of identified and quantified proteins to 531,
corresponding to 29% of all ORF products (Table S1). These
proteins were assigned to 20 functional categories (Figure 1) based
on GO terms [17]. Our protein set covers a wide range of cellular
functions, which suggests unbiased sampling of bacterial proteins,
a requirement for comparative proteomics studies.
Differentially regulated bacterial proteins under
tetracycline stress
The Rover tool developed by the Gevaert lab was used to
compare the proteomes of both bacterial samples [18]. Following
statistical analysis at 95% confidence, proteins with a protein ratio
less than 0.45 or higher than 7.83 were considered as significantly
up or down-regulated (p,0.05), with high ratio values pointing to
proteins that were more abundant in non-treated bacteria. The
broad distribution of protein ratios shown in Figure 2 can be
interpreted as though we were dealing with two very different
proteomes and thus likely indicates that large proteome adapta-
tions occur under conditions of antibiotic stress.
In total, 24 proteins were found significantly regulated upon
doxycycline treatment; 5 proteins were up-regulated, whereas 19
proteins were down-regulated as a result of doxycycline treatment.
Table S2 summarises the information obtained through in silico
analysis of these 24 proteins.
PSORTb v.3.0 was further used to allocate the identified
proteins to the cytoplasm, the cytoplasmic membrane, the
periplasmic space, the outer membrane or to extracellular sites.
5 proteins were annotated to reside in the cytoplasm, 3 in the
cytoplasmic membrane, 1 was in the periplasmic space, but the
majority (15) had no known localization. The regulated proteins
are involved in energy metabolism (2/24), transport and binding
(4/24), protein fate (2/24), amino acid biosynthesis (2/24),
biosynthesis of cofactors (1/24), purine and pyrimide (1/24),
DNA metabolism (1/24) and detoxification (1/24). Finally, the
overrepresentation of proteins with unknown function (10/24) is of
particular note (Table S2).
Discussion
The aim of the present study was to analyze how the proteome
profile of C. burnetii changed upon tetracycline stress, with the goal
of providing insights into as of yet unexplored mechanisms of
tetracycline resistance, which might eventually point to protein(s)
that could be considered for targeting when developing novel
drugs. Comparison of the proteome profiles of the two C. burnetii
samples indeed pointed to several proteins with regulated
expression under tetracycline stress conditions, and these proteins
are discussed in the following sections.
Up-regulated proteins under tetracycline stress
conditions
5 proteins were found to be up-regulated upon doxycycline
treatment. The predicted cellular functions of these proteins were
protein and peptide secretion and trafficking (Q83CL5), energy
metabolism, pentose phosphate pathway (Q83DM4), biosynthesis
of pantothenate and coenzyme A (Q83EA2), aspartate biosynthe-
sis (Q83A62) and DNA replication (Q83C00).
Signal peptidase I (SPI) (Q83CL5) belongs to a group of serine
proteases [19], and plays an essential role in the processing of
preproteins carrying a typical N-terminal signal peptide, upon
translocation across the cytoplasmic membrane [20]. Previous
Table 1. Synopsis of the protein identification results from the methionine-COFRADIC analysis following stringent filtering of
peptide-to-spectrum matches.
Study Technique Proteome digestion Labelling
Obtained
spectra
Methionine
containing
peptides
Unique
peptides
Unique
proteins
Quantified
proteins
Q212 Methionine-
COFRADIC
Endoproteinase Lys-C
12C3-propionate 13,271 8,208 1,998 800 531
Q212Dox Methionine-
COFRADIC
Endoproteinase Lys-C
13C3-propionate 13,271 8,208 1,998 800 531
The analysis of the samples, C. burnetii cultured in presence of tetracycline (Q212Dox) or absence of the antibiotic (Q212) led to the acquisition of 13,271 MS/MS-spectra.
Following filtering, 531 proteins common to both samples were identified.
doi:10.1371/journal.pone.0033599.t001
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encoding for SPI (lepB) interrupted cell growth and division
[21,22]. Many membrane and secreted bacterial proteins are
synthesized as precursors with an N-terminal signal peptide that
contains 15 to 30 amino acids. SPases catalyze processing of these
signal peptides, thereby allowing protein secretion from the
membrane [23,24]. Bacterial SPases consist of single polypeptides
that are anchored in the membrane by one or two transmembrane
regions. The most studied SPase is that of E. coli, which spans the
membrane twice [23], similar to the here identified SPI. The
direct link between cell growth and division, and increased
expression of SPI, suggests the possible existence of a mechanism
of C. burnetii to survive under tetracycline stress conditions.
Furthermore, the functional relation of this protein with secreted
and membrane proteins suggests a possible role for additional
activation of such proteins by SPI and thus a more active mode of
excretion of the antibiotic. Type I SPases can be irreversibly
inhibited by certain penem compounds that acylate the serine
residue in the active site. Since SPase activity was found to be
essential for cell viability, SPases are considered to be potential
targets for developing novel antibacterial agents [19,25]. Our
study also places C. burnetii SPI as a possible target for inhibition by
penem derivatives.
Transaldolase (Q83DM4) functions in the pentose phosphate
pathway and is almost ubiquitously found in the three domains of
life (Archaea, Bacteria, and Eukarya). It provides cells with
important redox cofactors such as NADPH, building blocks for
nucleotide and nucleic acid biosynthesis [26]. Although increased
expression rates of this protein in novobiocyn-resistant Staphylococ-
cus aureus strains has been reported, its increase was not associated
with a possible mechanism of bacterial resistance against
antibiotics [27]. It is however likely though that transaldolase
over-expression upon doxycycline administration can balance the
probably increased demand of the bacterium for energy to excrete
the antibiotic.
The DNA polymerase III alpha subunit (Q83C00) might also be
associated with a molecular mechanism of antibiotic resistance.
This protein is considered to be the main mediator of pathogen
survival through induction of mutagenicity. It contributes to the
creation of mutants that are able to address the host immune
system and administered antibiotics [28].
3-methyl-2-oxobutanoate hydroxymethyltransferase (Q83EA2)
participates in the biosynthesis of pantothenate and coenzyme A
Figure 1. Classification of the 531 identified C. burnetii proteins according to their cellular function. These 531 proteins were identified
in both samples; i. e., C. burnetii cultured in presence of tetracycline and C. burnetii cultured with no antibiotic present.
doi:10.1371/journal.pone.0033599.g001
Table 2. The filtering criteria used for protein identification.
Filtering criteria
Withhold peptide-to-spectrum matches with Mascot score$Mascot’s identity
score at 99% confidence
Remove peptides shorter than 8 amino acids
Remove peptides with a score less than 10 points above the threshold
Remove peptides with a FALSE ratio
doi:10.1371/journal.pone.0033599.t002
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enzyme A has been implicated in resistance mechanisms against
aminoglycoside-based antibiotics (AGs). AGs bind to the 30S
subunit of the prokaryotic ribosome and interrupt bacterial protein
synthesis, a mode-of-action that is similar to that of tetracycline.
Coenzyme A is directly involved in the enzymatic covalent
modification of AGs, which causes a strong decrease in the AG’s
binding affinity to the prokaryotic ribosome [29].The fact that the
3-methyl-2-oxobutanoate hydroxymethyltransferase is over-ex-
pressed upon doxycycline treatment possibly indicates a similar
function of C. burnetii’s coenzyme A to tetracycline resistance.
Methyltetrahydropteroyltriglutamate–homocysteine methyl-
transferase (Q83A62) was also over-expressed upon doxycycline
treatment. This enzyme is involved in methionine biosynthesis
(http://cmr.jcvi.org/cgi-bin/CMR/CmrHomePage.cgi). Despite
extensive literature search however, no connection between
methionine biosynthesis and antibiotic resistance mechanisms
was found.
Down-regulated proteins under tetracycline stress
conditions
19 proteins were down-regulated under tetracycline stress
conditions. Their predicted cellular functions were diverse,
including protein folding and stabilization-heat response
(Q83CE9), aspartate biosynthesis (P24703), detoxification
(Q83AQ8), threonine catabolic process (Q83F39), purine ribonu-
cleoside salvage (Q83FC4), transport and binding (Q83BF9,
Q82OW5, Q83DI7 and Q83AW2) and unknown function (B5-
QSC3, B5QSC0, Q83A96, Q83EA1, Q83EJ9, Q83A79, Q83-
D04, Q83DR4, Q83B41 and Q83CL9). One example of the latter
is ScvA (B5QSC0), a highly basic DNA binding protein specific for
the small cell variant (SCV) of C. burnetii and believed to play role
in chromatin condensation [30]. Interestingly, ScvA was found
down-regulated in a similar study but using levofloxacine stress
[31], and its down-regulation under tetracycline stress conditions
agrees with the levofloxacine study in which it was hypothesized
that SCVs of C. burnetii are predominantly present in antibiotic-
free cultures. The putative uncharacterized protein B5QSC3 was
also down-regulated upon antibiotic stress. In fact, 8 out of the 19
down-regulated proteins have currently no known function, which
highlights the need for future studies towards characterizing C.
burnetii’ s proteome.
Down-regulation of the phosphoenolpyruvate-protein phospho-
transferase (Q83BF9) is of particular interest. This protein was
identified in a previous study in which a persistent model of C.
burnetii infection was compared with an acute one, and found to be
only present in the acute strain [32].
Levels of the ferrous iron transport protein B (Q83AW2) were
also found to be down-regulated. Iron (Fe
2+) is a cofactor in a
variety of biological processes and many bacteria transport iron
through Feo systems (ferrous iron transport). It has been suggested
that bacterial iron metabolism is relevant for the activity of
Figure 2. Statistical analysis using 95% confidence settings for determining the limits of protein log2 ratio values linked to
differential regulation. These limits are .3.415 and ,21.234. Thus, a protein with a value ,21.234 indicates higher abundance upon antibiotic
stress, whereas a protein with a value .3.415 indicates higher abundances in the absence of antibiotic.
doi:10.1371/journal.pone.0033599.g002
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metabolism might challenge bacterial antibiotic susceptibility [33].
In this respect, it was shown that deletion of the gene encoding for
ferric reductase confers resistance to antibiotics in Pseudomonas,
whereas its over-expression accelerates antibiotics-induced cell
death [34]. Many pathogens show reduced pathogenicity in the
absence of this protein, reflecting the importance of iron
absorption [35]. It has been suggested that elevated iron transport
triggers the activation of immune cytokines [36,37]. Taken
together, our and previous data hint to the possibility that
tetracycline-challenged C. burnetii down-regulate iron transport to
avoid cytokine activation.
Although the regulated proteins here identified could not be
directly linked to known mechanisms of antibiotic resistance,
closer inspection revealed several known proteins that lie on the
limits of statistically significant under/over-expression. A charac-
teristic protein is the ribosome associated factor Y (pY, Q83DI6)
found down-regulated upon doxycycline treatment (ratio value of
7.54). Ribosomes are clearly of utmost importance for controlling
protein expression. The pY protein has been studied in E. coli and
is expressed under low temperature [38] or excessive cell
concentration [39]. It inhibits translation, probably analogous to
the action of tetracycline, thus by preventing the association of
aminoacyl-tRNA in the ribosomal A site [40]. By lowering pY
expression, C. burnetii might try to increase protein synthesis,
thereby addressing protein synthesis inhibition by tetracycline. In
support of this hypothesis are the results of the study by Agafonov
and co-workers who demonstrated that association of tetracycline
with the ribosomal A site in E. coli was not affected by the presence
of large amounts of pY [40]. Also the reverse hold true since the
interaction of pY with ribosomes was not affected by tetracycline
[41]. Therefore, protein inhibiting protein synthesis and antibiotics
do not interfere with each other for association with ribosomes,
thus excluding possible competition for the ribosomal A site.
Of further note is that the vast majority of the proteins with
predicted role in translation and protein biosynthesis (69 out of 77
proteins identified) had protein ratio values that place them at the
border of statistically significant over-expressed proteins upon
doxycycline treatment. Furthermore, stretching the limits for
statistical significance a bit, of the additional 158 proteins with
ratio values up to 1.1, the predicted cellular function of 52 of them
was translation and protein biosynthesis. This observation,
coupled to the mode of action of tetracyclines leads us to suspect
the existence of a mechanism protective for bacterial ribosomes, a
well-known tetracycline resistance mechanism. Tetracycline resis-
tance by expressing ribosomal protection proteins (RPPs) is
achieved by weakening the interaction of tetracycline and the
ribosome with subsequent antibiotic release [42]. RPPs free
ribosomes from the inhibitory effects of drugs, such that aa-tRNA
can re-bind to the A-sites and protein synthesis can continue.
Although it is believed that RPPs work as tetracycline resistant
elongation factors to carry out protein synthesis in the presence of
tetracycline, substitution experiments have ruled out this hypoth-
esis [43]. Common characteristics of RPPs are their molecular size
(approximately 72.5 kDa) and their high amino acid sequence
homology to translation elongation factors EF-Tu and EF-G
GTPases [44]. In this context, the here identified elongation factor
4 (Q83BK3) is predicted to be required for accurate and efficient
protein synthesis under certain stress conditions. This protein
possesses all the main characteristics of a RPP, it is classified as a
GTPase, its molecular weight is 67.8 kDa and it shares high
sequence homology to elongation factor proteins Tu and G. In
addition, elongation factor 4 was shown to contribute to tellurite
resistance in Escherichia coli without an apparent role in the fidelity
of protein synthesis, suggesting a role in tetracycline resistance
[45].
As mentioned before, active efflux of tetracycline from bacteria
is the second most predominant tetracycline resistance mechanism
in clinical settings. This efflux mainly occurs via integral
membrane transporters that belong to the major facilitator
transporter superfamily (MFS) [46]. These efflux pumps span
the lipid bilayer of the inner cell membrane 12 to 14 times. Based
on homology to known transporters, the membrane spanning
regions of these proteins are predicted to be helical, forming a
water-filled channel surrounded by six transmembrane helices.
Tetracyclines are predicted to pass through this channel and
exchanged for H
+ [47]. One MFS protein (Q83EP3) and a Na
+-
driven multidrug efflux pump (Q83DC6) have been identified in
our study. In silico analysis of these proteins identified 11 and 12
transmembrane helices, respectively (http://www.cbs.dtu.dk/ser-
vices/TMHMM-2.0/), and thus, these proteins could be capable
of secreting tetracycline.
The fact that certain antibiotics may be signaling molecules at
low concentrations [48,49,50,51,52], along with the idea that the
original function of antibiotic resistance determinants is not
counteracting the activity of drugs [53,54], leads to the suggestion
that antibiotic resistance elements might have been primarily
selected for playing roles relevant for microbial physiology, while
their activity in avoiding the action of antimicrobials is secondary
to these roles [53,55,56,57]. In support of this comes the finding
that building up the intrinsic antibiotic resistance phenotype
requires the concerted activity of a large number of elements,
several of which play primary roles in microbial physiology,
including proteins and elements of the bacterial metabolic
networks such as components of the electron transport chain or
of the metabolism of amino acids, fatty acids or nucleotides
[51,58,59,60]. The findings from our study further support this
concept. Even though there was no statistically significant
regulation of proteins known to participate in antibiotic resistance
mechanisms, several proteins of the pathogen’s metabolism were
differentially regulated, indicating a concerted activity in the
bacterium to modulate antibiotic resistance using its metabolism.
An analogous conclusion can be drawn from a previous
proteomics study on a levofloxacine-resistant C. burnetii strain
[31]. Taking into account that cellular processes are carried out by
proteins and not DNA, we propose that, at least concerning C.
burnetii, when referring to antibiotic resistance, one may not simply
limit the potential mechanisms of resistance to those already
known from other studies. Instead, we must consider that
resistance to an antibiotic is not exclusively the result of a mutated
gene, but rather a multifaceted process as indicated by the
proteome rearrangements observed in this study.
Conclusions
Quantitative proteome comparison of a C. burnetii strain
propagated under tetracycline stress conditions with an antibiot-
ic-free cultured strain identified 5 up-regulated and 19 down-
regulated proteins upon tetracycline stress. The predicted cellular
functions of the differentially regulated proteins include secretion
and trafficking, energy metabolism, amino acid biosynthesis, DNA
metabolism and protein fate. Several plausible hypotheses have
been formed to establish a link between these proteins and
tetracycline stress conditions. Our further analysis of the identified
proteins indicated the proteome potential of C. burnetii to resist
tetracycline. Higher antibiotic concentrations or a proteome
analysis of a tetracycline resistant C. burnetii clinical isolate could
further indicate proteins that are directly implicated in tetracycline
C. burnetii Proteomics in Presence of Tetracycline
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and minimization of treatment failures.
Materials and Methods
C. burnetii culture in the presence of tetracycline
C. burnetii Q212 (CbuG_Q212) phase II Q fever reference strain
was propagated in confluent African Green Monkey kidney
fibroblasts (Vero; ATCC no. CCL- 81) in 225 cm
2 angled neck
flasks (Corning Inc., U.S.A.). Infected cells were cultured in
minimum essential medium (MEM; Gibco Laboratories) supple-
mented with 4% fetal bovine serum (FBS; Gibco Laboratories and
2 mM L-glutamine (Gibco Laboratories) at 35uC in a 5% CO2
incubator. Infection was monitored by Gimenez staining [61].
Briefly, Vero cells were inoculated and cultured in medium free of
antibiotics until 90% of the cells were infected. The supernatant
was removed and infected cells were harvested and centrifuged at
10006g for 15 min. The pellet was re-suspended in fresh culture
medium, and the cells were disrupted by three freeze-thaw cycles
(from 2210uCt o3 7 uC). After centrifugation at 10006g for
15 min, the supernatant with the liberated bacteria from the
infected cells was used to infect fresh Vero cell monolayers. The
inoculum was removed after 1 h of incubation at 35uCi na5 %
CO2 atmosphere, the cells were washed with culture medium in
order to eliminate unphagocytosed bacteria, and fresh medium
containing 0.2 mg/L of doxycycline (DOX) was added. The
monolayer was incubated at 35uC in a 5% CO2 atmosphere. The
supernatant was removed every three days, and fresh medium
containing 0.2 mg/L of DOX was added. The same procedure
was followed with constantly increasing concentrations of the
antibiotic until bacteria were collected for inoculation titration test
and MIC determination [62]. Parallel cultures of the same strain
were kept at all times undergoing the same experimental
procedures with absence of the antibiotic so as to serve as the
reference strain (Q212).
The antibiotics used in this study was doxycycline hydrochloride
(DOX) (a-6-deoxy-5-hydroxytetracycline, Vibramycin, Hyclate,
Calbiochem, Merck KGaA, Germany). DOX was directly diluted
into freshly prepared culture medium to the appropriate
concentration. Culture media containing the antibiotics were
sterilized by filtration (pore size: 0.22 mm) and stored at 4uC.
DOX was shown, by shell vial assay (data not included), to be
nontoxic to Vero cells to concentrations up to 128 mg/L.
C. burnetii inoculation titration test and MIC
determination
To determine the effect of tetracycline in the culture medium on
the MIC of C. Burnetii, inoculation titration tests and Minimum
Inhibitory Concentration determinations were performed as
described previously [31]. After six days of incubation at 35uC,
5% CO2, the MIC of DOX was determined by direct
immunofluorescence as the concentration of the antibiotic at
which there were no intracellular bacteria observed following a six
days incubation period. Even though during MIC determination
tests bacteria were initially challenged by an initial concentration
well beyond the MIC mentioned in the literature for C. burnetii
Q212 (2 mg/L; initial antibiotic concentration, 0.125 mg/L),
negative controls (no antibiotic present) were included at all times.
During C. burnetii culture under tetracycline stress conditions (15
weeks), the observed MIC for doxycycline increased from 2 mg/l
to 16 mg/l (MIC Q212Dox: 16 mg/l), while bacteria propagated
in the absence of antibiotic for the same time period, did not show
a MIC change (MIC Q212: 2 mg/l).
Bacteria and protein isolation
Bacteria propagated with DOX (Q212Dox) and without DOX
(Q212) were mass cultured in parallel and under identical
conditions for 10 days (with the exception of doxycycline present
in Q212Dox) and finally isolated from their host cells using
renographin (Ultravist 370; 0.769 g/mL iopromide; Schering)
density gradient ultracentrifugation as described [17]. Renogra-
phin clean bacteria re-suspended in K36 buffer (16.5 mM
KH2PO4, 33.5 mM K2HPO4, 100 mM KCl, 15.5 mM NaCl,
pH 7.0) containing a protease inhibitor cocktail (Sigma-Aldrich)
underwent five 5-min freeze-thaw cycles (from 2210uCt o3 7 uC)
and the protein concentration was determined by the Bradford
assay. All manipulations involving viable bacteria were performed
in a Biosafety Level III laboratory. It has to be noted that upon
completion of the experiments all bacteria cultured under
tetracycline stress conditions were killed by incubation in 8%
formaldehyde at room temperature for 24 h followed by
autoclaving. Prior to disposal, bacteria were used to inoculate
Vero cells to check their inactivation.
Isolation and identification of methionine-containing
peptides by COFRADIC
The methionine-COFRADIC procedure was performed on
both Q212Dox and Q212 whole lysates as described [16]. In
brief, proteomes were digested with endoproteinase Lys-C and
the peptides were labeled by N-propionylation. The Q212
proteome digest was labeled with
12C3-propionate whereas the
Q212Dox proteome digest with
13C3-propionate. Each peptide
thus had a label on its N-terminal alpha-amino group and on its
C-terminal lysine epsilon-amino group, evoking a difference of
6 Da between light and heavy peptides. Samples were mixed and
analyzed by LC-MS/MS on an Ultimate 3000 HPLC system
(Dionex, Amsterdam, The Netherlands) in-line connected to a
LTQ Orbitrap XL mass spectrometer (Thermo Electron,
Bremen, Germany). Instrument settings for LC-MS/MS analysis
and generation of MS/MS peak lists were as described [63].
MS/MS peak lists were searched with Mascot using the Mascot
Daemon interface (version 2.2.0, Matrix Science). The Mascot
search parameters were as follows. Searches were performed in a
Coxiella burnetii database downloaded from Uniprot on June 17
th,
2009 (containing 1,815 protein entries). Lys-C/P was set as the
used protease with one missed cleavage allowed, and the mass
tolerance on the precursor ion was set to 610 ppm and on
fragment ions to 60.5 Da. S-carbamidomethylation of cysteine
and oxidation of methionine (to its sulfoxide) were set as fixed
modifications. In addition, Mascot’s C13 setting was set to 1.
The light and heavy labels were defined in Mascot Distiller’s
quantitation method. Peptide quantifications were carried out
using the Mascot Distiller Quantitation Toolbox (version 2.2.1).
The quantification method details were as follows: constrain
search: yes, protein ratio type: average, report detail: yes,
minimum peptides: 1, protocol: precursor, allow mass time
match: yes, allow elution shift: no, all charge states: yes. Ratios
for identified proteins were calculated by comparing the XIC
peak areas of all matched light peptides with those of the heavy
peptides, and the results were verified by visual inspection of MS
spectra with the in-house developed Rover tool [18]. All
identified MS/MS spectra are publicly available in the PRIDE
database (http:www.ebi.ac.uk/pride) under the experiment
number 18640 (note that currently only referees can examine
these data using the login: review23777, and password:
x_MgR4R$).
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Analysis of the amino acid sequences of all identified proteins
was carried out using several Web-based software tools, freely
accessible from the ExPASy Proteomics Server of the Swiss
Institute of Bioinformatics (SIB) (http://au.expasy.org/). The
purpose of this analysis was to calculate the molecular weight
(MW) and isoelectric point (pI) of each protein using the software
ProtParam Tool (http://au.expasy.org/tools/protparam.html)
and Compute pI/Mw Tool (http://au.expasy.org/tools/pi_tool.
html).
Supporting Information
Table S1 List of proteins identified in both C. burnetii samples.
All 531 proteins were identified in both samples (i. e. C. burnetii
cultured in presence of tetracycline and C. burnetii cultured with no
antibiotic present) in different expression levels. Proteins are
categorized according to their predicted cellular function; their
ratio value, gene locus, molecular weight (MW), isoelectric point
and predicted cellular function are indicated.
(DOCX)
Table S2 Proteins that were significantly over-expressed in C.
burnetii when cultured in presence of tetracycline (Q212Dox) or in
C. burnetii when cultured with no antibiotic (Q212).
(DOCX)
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